Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 453,60
A002 Cell Blood Count 27 1 983,98
A005 Sedimentation rate 16 1 175,69
A008 Reticulocytes 13 955,25
A009 Matching of blood and compatibility test 265 19 472,41
A010 Time of coagulation 13 955,25
A015 Time of bleeding 13 955,25
M125 Malaria test 67 4 923,21
URINE ANALYSIS
B500 Standard urine test 13 955,25
B502 Standard urine test with microscopy 24 1 763,54
B510 Urine pregnancy test (screening) 13 955,25
B511 Nechiporenko urine test 20 1 469,62
B512 Zimnitsky urine test 53 3 894,48
B513 3-portions urine test examination 40 2 939,23
B514 2-portions urine test examination 27 1 983,98
B515 Urine precipitate - Microscopy 13 955,25
B517 Creatinine Clearance 53 3 894,48
STOOL ANALYSIS
B306 Elastase Pancreatic 33 2 424,87
M105 Coprology total 27 1 983,98
M110 Coprology (occult blood) 13 955,25
M111 Carbohydrates in faeces 40 2 939,23
M115 Enterobiasis 20 1 469,62
M120 Eggs of helminths (+protozoa) 27 1 983,98
M122 Protozoa in faeces 20 1 469,62
M390 Adenovirus and rotavirus (in stool) 28 2 057,46
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 3 012,71
M391 Helicobacter pylori(in stool) 27 1 983,98
M393 Verotoxin in stool 50 3 674,04
M394 Norovirus in stool 25 1 837,02
M395 Calprotectin in stool (quantitative) 50 3 674,04
M396 Clostridium Difficile Toxin A & B 65 4 776,25
SPUTUM ANALYSIS
M150 Standard sputum test 27 1 983,98
M002 Nasal slime general clinical research 27 1 983,98
M355 M. Tuberculosis in sputum 33 2 424,87
SKIN& NAIL PLATES
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 453,60
M210 Demodex folliculorum 20 1 469,62
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 022,12
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 469,62
M221 Standard Cervical Smear Test 20 1 469,62
M222 Standard Urethral Smear Test 20 1 469,62
M223 Standard prostatic fluid test 27 1 983,98
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 1 983,98
B621 Standard Serous Fluid test 27 1 983,98
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 424,87
B623 Glucose in cerebrospinal fluid 17 1 249,17
B624 Protein in cerebrospinal fluid 17 1 249,17
HEMOSTASIS SYSTEM
A020 APTT 16 1 175,69
A025 Prothrombin+INR 27 1 983,98
A027 Thrombin time 22 1 616,58
A030 Fibrinogen 16 1 175,69
A035 Antithrombin III 27 1 983,98
C139 Protein-C 47 3 453,60
C142 Protein-S 47 3 453,60
C515 D-DIMER 60 4 408,85
C305 Lupus anticoagulant (panel) 53 3 894,48
A033 Platelet Aggregation 83 6 098,91
A031 FACTOR VON 170 12 491,74
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 204,42
BLOOD DRUG RATES
B142 Folic acid 27 1 983,98
T010 Digoxin 78 5 731,50
T015 Phenobarbital 53 3 894,48
T020 Phenytoin 53 3 894,48
T025 Valproic Acid 53 3 894,48
T030 Carbamazepine 53 3 894,48
T080 Tacrolimus 35 2 571,83
T085 Levetiracetam (Keppra) 100 7 348,08
NARCOTIC SCREENING
T035 Methamphetamine 33 2 424,87
T040 Cannabis 33 2 424,87
T045 Cocaine 33 2 424,87
T050 Opiates / QUICK TEST 33 2 424,87
T060 Сotinine 33 2 424,87
T070 Benzodiazepines 53 3 894,48
T075 Drug screening in urine 53 3 894,48
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 865,75
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 13 740,91
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 3 894,48
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 1 983,98
B102 Vitamin D 107 7 862,45
B103 Vitamin A 83 6 098,91
B104 Vitamin B1 83 6 098,91
B108 Vitamin B5 83 6 098,91
B109 Vitamin B6 83 6 098,91
B112 Vitamin C 83 6 098,91
B113 Vitamin E 83 6 098,91
B114 Vitamin K 83 6 098,91
B135 Albumin 13 955,25
B137 Homocysteine 67 4 923,21
B140 Creatinine 13 955,25
B155 Total protein 13 955,25
B160 Protein fractionation (Electrophoresis) 27 1 983,98
B170 Urea 13 955,25
B175 Uric acid 13 955,25
B604 Alpha-2-Macroglobuline 47 3 453,60
B610 Haptoglobin 47 3 453,60
B100 Glucose 13 955,25
B101 Standard glucose tolerance test 33 2 424,87
B107 Pregnancy glucose tolerance test 33 2 424,87
B180 Fructosamine 20 1 469,62
B430 Haemoglobin A1C 22 1 616,58
B105 Cholesterol 13 955,25
B110 Cholesterol-HDL 20 1 469,62
B115 Cholesterol-LDL 20 1 469,62
B120 Triglycerides 13 955,25
B165 Lipoprotein A 27 1 983,98
B166 APO-A-1 protein 27 1 983,98
B167 APO-B protein 27 1 983,98
B125 Bilirubin total 13 955,25
B130 Bilirubin direct 13 955,25
B145 Iron 16 1 175,69
B150 Iron binding capacity 20 1 469,62
B440 Transferrin 27 1 983,98
C415 Ferritin 27 1 983,98
B144 Zink 38 2 792,27
B148 Litium 74 5 437,58
B200 Calcium (total) 16 1 175,69
B202 Calcium (ionised) 20 1 469,62
B205 Sodium/Potassium/Chloride 16 1 175,69
B210 Magnesium 13 955,25
B007 Cuprum 22 1 616,58
B215 Phosphate inorganic 13 955,25
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 1 983,98
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 1 983,98
B300 Amylase 16 1 175,69
B305 Amylase pancreatic 16 1 175,69
B310 Lipase 16 1 175,69
B315 Lactatedehydrogenase (LDH) 13 955,25
B317 Erythropoietin 47 3 453,60
B320 Creatine Kinase 13 955,25
B325 Creatine Kinase MB 16 1 175,69
B330 Gamma Glutamyle Transferase (GGT) 13 955,25
B335 Acid phosphatase 16 1 175,69
B340 Alk. Phosphatase 13 955,25
B345 Alanine Amino Transferase (ALT) 13 955,25
B350 Aspartate Amino Transferase (AST) 13 955,25
B360 Cholinesterase 18 1 322,65
B362 С1 Esterase Inhibitor 45 3 306,64
B400 C-Reactive Protein 20 1 469,62
B401 C-reactive protein high sensitivity 30 2 204,42
B405 Rheumatoid Factor 20 1 469,62
B410 Anti-streptolysin O titre 20 1 469,62
B411 Alfa-1-antitrypsin 27 1 983,98
B435 Myoglobin 47 3 453,60
B445 Troponin I 47 3 453,60
B450 Troponin T 47 3 453,60
B451 BNP (brain natriuretic peptide) 87 6 392,83
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 865,75
B003 Ceruloplasmin 50 3 674,04
B004 Eosinophil Cationic Protein (ECP) 50 3 674,04
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 11 022,12
B118 Lactate 25 1 837,02
B122 Angiotensin converting enzyme (ACE) 45 3 306,64
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 9 552,50
B702 Procalcitonin (quant) 60 4 408,85
B556 The N-terminal peptide NT-proBNP 88 6 466,31
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 453,60
B025 Microproteinuria 13 955,25
B132 Urea (random portion) 12 881,77
B133 Uric acid (random portion) 12 881,77
B139 The content of Cu (copper) in the urine (a single portion of urine) 12 881,77
B173 Glucose (random portion) 13 955,25
B182 Alpha Amylase (random portion) 18 1 322,65
B505 NA+/K+/Cl (random portion) 20 1 469,62
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 022,12
B134 Calcium (random portion) 18 1 322,65
B008 The content of Cu (copper) in the urine (daily) 13 955,25
B703 Gas chromatography of urine (organic aciduria) 250 18 370,20
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 322,65
B141 Creatinine (24h) 18 1 322,65
B171 Urea (24h) 18 1 322,65
B176 Uric acid (24h) 18 1 322,65
B177 Phosphate inorganic (24h) 18 1 322,65
B178 Magnesium (24) 18 1 322,65
B179 Glucose (24h) 18 1 322,65
B183 Total Protein (24h) 18 1 322,65
B506 Na (24h) 20 1 469,62
B507 K (24h) 20 1 469,62
B508 Cl (24h) 20 1 469,62
B516 Calcium urine test (24h) 22 1 616,58
B550 Oxalate in urine 40 2 939,23
B555 5-hydroxyindoleacetic acid in urine 53 3 894,48
B558 Beta-2-microglobulin in urine 24 1 763,54
B562 Urine protein electrophoresis 40 2 939,23
B520 Stone chemistry - Profile 67 4 923,21
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 396,14
B420 Immunoglobulin M (IgM) 19 1 396,14
B425 Immunoglobulin G (IgG) 19 1 396,14
C299 Circulating Immune Complex 22 1 616,58
C300 IgE total 27 1 983,98
C285 Interferon sensibility state 293 21 529,87
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 14 696,16
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 14 696,16
C293 Compliment Componenta C3 33 2 424,87
C294 Compliment Componenta C4 33 2 424,87
C295 Neutrophilic Bactericidal Activity (HCT test) 27 1 983,98
C290 Interleukin 6 34 2 498,35
C291 Interleukin 8 34 2 498,35
C296 Interleukin 10 34 2 498,35
C298 Tumor Necrosis Factor 34 2 498,35
C281 Interleukin 1 Beta 50 3 674,04
B704 Oligoclonal IgG in liquorrhea & serum 120 8 817,70
Diagnosis Of Auto-Immune Diseases
C225 Thyroglobulin antibody 33 2 424,87
C230 Thyroperoxidase antibody 33 2 424,87
C231 Auto AB TSH-receptor 53 3 894,48
C233 Antispermatic Antibodies 67 4 923,21
C235 AB Insulin IgG 40 2 939,23
C236 AB insular beta-cells 67 4 923,21
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 571,83
C500 Nuclear antibody (IF) 47 3 453,60
C505 Cardiolipin antibody IgG 47 3 453,60
C506 Cardiolipin antibody IgA 25 1 837,02
C533 Anti-dsDNA 53 3 894,48
C534 Anti-ssDNA 53 3 894,48
C535 Phospholipid Antibody IgG 53 3 894,48
C536 Phospholipid Antibody IgM 53 3 894,48
C830 Antibodies Prothrombin 40 2 939,23
C845 Antibodies Reticulin 47 3 453,60
C846 Antibodies Endomysium 47 3 453,60
C847 Antibodies Platelet 53 3 894,48
C848 Antibodies Basic Skin Membrane 73 5 364,10
C840 Antibodies Gliadin IgA 40 2 939,23
C850 Antibodies Gliadin IgG 40 2 939,23
C841 Anti-Transglutaminase IgG 47 3 453,60
C842 Anti-Transglutaminase IgA 47 3 453,60
C023 Cardiolipin antibodies, IgM 50 3 674,04
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 6 098,91
C035 Cytoplasmic antigen antibodies Jo-1 (anti-Jo-1) 83 6 098,91
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 674,04
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 674,04
C851 Beta2 – glycoprotein antibodies 50 3 674,04
C852 Annexin V antibodies 50 3 674,04
C853 ENA – extractive nuclear antibodies screen 61 4 482,33
C101 Anti-smooth muscle antibodies (ASMA) 50 3 674,04
C102 Anti-mitochondrial antibodies (AMA) 50 3 674,04
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 306,64
C203 Scl-70 antibodies 50 3 674,04
C240 Antibodies acetylcholine receptor 160 11 756,93
C241 Antibodies aquaporin 4( NMO) 80 5 878,46
C242 Antibodies skeletal muscles 70 5 143,66
C243 Antibodies gangliosides, blot 90 6 613,27
C244 Myositis antibodies, blot 90 6 613,27
C245 Anti-neuronal antibodies, blot 110 8 082,89
C246 Antibodies NMDA receptor 150 11 022,12
C247 Antibodies Sm 50 3 674,04
C248 Antibodies gliadine deamidated peptides IgG 45 3 306,64
C249 Antibodies gliadine deamidated peptides IgA 45 3 306,64
C250 Antibodies RNP-70 45 3 306,64
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 21 162,47
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 21 456,39
C253 Blood test on APG 100 7 348,08
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 50 3 674,04
C256 Definition of CD20 in peripheral blood 54 3 967,96
C257 Typing of CD-34 + cells 54 3 967,96
C258 Myelogram 122 8 964,66
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 16 165,78
ONCOLOGICAL TESTS
C405 PSA total 29 2 130,94
C410 PSA free 29 2 130,94
C420 AFP 29 2 130,94
C425 CEA 29 2 130,94
C430 CA 125 38 2 792,27
C435 CA 19-9 29 2 130,94
C440 CA 15-3 29 2 130,94
C442 CA 72 - 4 40 2 939,23
C443 Neuron-Specific Enolase (NSE) 60 4 408,85
C445 B2 microglobulin 33 2 424,87
C820 Cyfra-21-1 40 2 939,23
C822 Squamous Cell Carcinoma (SCC) 39 2 865,75
C821 UBC (Bladder Cancer Antigen) in urine 39 2 865,75
C823 HE4 40 2 939,23
C824 Chromogranin A 55 4 041,44
SEROLOGY
Syphilis Diagnosis
S000 Syphilis RPR 27 1 983,98
S001 Antibodies Treponema Pallidum IgG+IgM 27 1 983,98
S002 Total antibodies Treponema pallidum (quant) 30 2 204,42
S010 Syphilis TPHA 33 2 424,87
S091 Immunoblot Treponema pallidum IgG 103 7 568,52
S092 Immunoblot Treponema pallidum IgM 103 7 568,52
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 424,87
A055 Antierythrocytic antibodies (screening) 40 2 939,23
A056 Direct Cumbs test 33 2 424,87
A061 Detecting Kell antigen sistem 33 2 424,87
A064 Phenotyping Rh and Kell 35 2 571,83
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 453,60
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 804,98
C004 Anti-HAV total 40 2 939,23
C006 Anti-HAV IgM 47 3 453,60
C008 HBsAg 27 1 983,98
C009 HBsAg (conf.test) 47 3 453,60
C010 HBeAg 47 3 453,60
C012 Anti-HBc total 40 2 939,23
C014 Anti-HBc IgM 47 3 453,60
C016 Anti-Hbe 47 3 453,60
C018 Anti-HBs quant. 47 3 453,60
C020 Anti-HCV total/ Anti-HCV IgG 40 2 939,23
C021 Anti-HCV IgM 44 3 233,16
C025 Anti-HCV (conf.test) 53 3 894,48
C007 Hepatitis D Virus HDV antibodies, total 28 2 057,46
C011 HDV antibodies, IgM 28 2 057,46
C013 HEV antibodies, IgG 28 2 057,46
C015 HEV antibodies, IgM 28 2 057,46
C026 Anti-CMV IgG 29 2 130,94
C028 Anti-CMV IgM 33 2 424,87
S200 Cytomegalovirus (CMV) IgG Avidity 53 3 894,48
C030 Anti-Rubella IgG 29 2 130,94
C032 Anti Rubella IgM 33 2 424,87
S210 Rubella IgG Avidity 38 2 792,27
C031 Anti-Parvovirus B19 IgG 40 2 939,23
C033 Anti-Parvovirus B19 IgM 40 2 939,23
C034 Anti Mumps IgG 53 3 894,48
C036 Anti Mumps IgM 53 3 894,48
C038 Anti Measles IgG 53 3 894,48
C040 Anti Measles IgM 53 3 894,48
C044 Anti-HSV 1 IgG 47 3 453,60
C046 Anti-HSV 1 IgM 53 3 894,48
C048 Anti-HSV 2 IgG 47 3 453,60
C050 Anti-HSV 2 IgM 53 3 894,48
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 453,60
C052 Anti-Varicella Zoster IgG 53 3 894,48
C054 Anti Varicella Zoster IgM 53 3 894,48
C058 Anti-EBV-VCA IgG 53 3 894,48
C060 Anti-EBV-VCA IgM 53 3 894,48
C450 Adenovirus infection 67 4 923,21
C856 Anti- encephalitis IgG 55 4 041,44
C857 Anti- encephalitis IgM 55 4 041,44
C094 IgG Respiratory syncytial virus 35 2 571,83
C096 IgM Respiratory syncytial virus 35 2 571,83
C152 IgG Dengue virus 25 1 837,02
C153 IgM Dengue virus 25 1 837,02
C154 Antibodies to Clostridium tetani (quantitative) 35 2 571,83
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 4 041,44
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 4 041,44
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 453,60
C064 Helicobacter pylori antibody blot 80 5 878,46
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 453,60
C080 Mycobacterium tuberculosis antibodies total 53 3 894,48
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 4 923,21
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 4 923,21
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 4 923,21
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 9 552,50
C090 Borrelia burgdorf. IgG (qual) 67 4 923,21
C091 Borrelia burgdorf. IgM (qual) 67 4 923,21
C519 Anti IgG Legionella pneumophila (qual.) 89 6 539,79
C522 Anti IgM Legionella pneumophila (qual.) 89 6 539,79
C645 Brucella IgG 67 4 923,21
C647 Brucella IgM 67 4 923,21
D070 Chlamydia pneumoniae IgA 53 3 894,48
D071 Chlamydia pneumoniae IgG 53 3 894,48
D072 Anti IgM Chlamydia pneumoniae 53 3 894,48
D073 Chlamydia psittaci IgG (qual) 67 4 923,21
D074 Chlamydia psittaci IgM (qual) 67 4 923,21
D077 Chlamydia psittaci IgA (qual) 67 4 923,21
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 102,21
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 734,81
D110 Mycoplasma pneumoniae IgA (quant) 40 2 939,23
D115 Mycoplasma pneumoniae IgG (qual) 40 2 939,23
D120 Mycoplasma pneumoniae IgM (qual) 40 2 939,23
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 204,42
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 204,42
D322 AB Shigella flexneri (total) 60 4 408,85
D323 AB Shigella sonnei (total) 60 4 408,85
S070 Ureaplasma urealiticum IgA 67 4 923,21
S075 Ureaplasma urealiticum IgG 67 4 923,21
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 616,58
S232 Anti-Salmonella Typhi Vi-antigen 22 1 616,58
S233 Anti-Corinebacterium Diphtheriae 22 1 616,58
C053 Helicobacter pylori IgM 44 3 233,16
C063 Helicobacter pylori IgA 44 3 233,16
C103 Immunoblot Borrelia burgdorferi IgG 60 4 408,85
C104 Immunoblot Borrelia burgdorferi IgM 60 4 408,85
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 734,81
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 734,81
S006 Antigen Legionella pneumophilla in urine 30 2 204,42
S007 Determination of antigen Legionella pneumophilla in urine (express test) 25 1 837,02
S008 Determination of streptococcus pneumoniae antigen 25 1 837,02
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 4 923,21
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 4 923,21
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 4 923,21
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 4 923,21
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 453,60
D312 Lamblia intestinalis IgM 47 3 453,60
D315 Antibody to ascaris antigen IgG (qual.) 40 2 939,23
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 4 923,21
D325 Antibodies to Opistorchis IgG (quantitatives) 67 4 923,21
D326 Antibodies to Toxocara IgG (quantitative) 67 4 923,21
D327 Antibodies to Trichinella lgG (quantitative) 67 4 923,21
D328 Antibodies Ascaris IgG (quantitative) 67 4 923,21
C049 Strongyloides stercoralis antibodies 44 3 233,16
C051 Taenia solium antibodies, IgG 44 3 233,16
C055 Fasciola hepatica antibodies, IgG 44 3 233,16
C057 Schistosoma mansoni antibodies, IgG 44 3 233,16
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 130,94
C024 Toxoplasma gondii IgM (qual) 38 2 792,27
C037 Leishmania infantum antibodies 60 4 408,85
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 233,16
S230 Trichomonas antibodies 30 2 204,42
S220 Toxoplasma IgG Avidity 46 3 380,12
C625 Entamoeba sp AB (total) 80 5 878,46
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 1 983,98
C205 Total T3 27 1 983,98
C210 Free T3 27 1 983,98
C215 Total T4 27 1 983,98
C220 Free T4 27 1 983,98
C222 Calcitonin 40 2 939,23
C223 Thyroglobulin 40 2 939,23
C224 Thyroid Binding Globulin (TBG) 40 2 939,23
Reproduction
B151 Dihydrotestosterone 53 3 894,48
C100 Follicle stimulating hormone 29 2 130,94
C105 Luteinising hormone 29 2 130,94
C106 Globulin, linking sex hormones (SHBG) 47 3 453,60
C110 Testosterone 29 2 130,94
C115 Prolactin 29 2 130,94
C117 Testosterone Free 47 3 453,60
C122 Prostate Health Index  (PHI) 180 13 226,54
C125 Estradiol 29 2 130,94
C126 Estriol Free 38 2 792,27
C130 Progesterone 29 2 130,94
C141 Inhibin В 93 6 833,71
C143 AMH (Anti-Mullerian Hormone) 93 6 833,71
C227 Androstenedione 60 4 408,85
C400 Beta HCG 33 2 424,87
C402 PAPP-A 44 3 233,16
C404 Androstanediol glucuronide 50 3 674,04
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 70 5 143,66
IVF83 Evaluation of ovarian reserve 197.6 14 519,81
AMH (Anti-Mullerian Hormone)
Follicle stimulating hormone
Fertility specialist consultation
C460 Determination of chorionic gonadotropin, (free Beta-subunit), ASTRAIA program 64 4 702,77
C461 Determination of plasma protein A (PAPP-A), ASTRAIA program 64 4 702,77
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 792,27
B536 Free cortisol (urine, 24h) 40 2 939,23
B531 17-alpha-Hydroxy-Progesteron 29 2 130,94
C120 Cortisol 29 2 130,94
C135 Dehydroepiandrosterone 33 2 424,87
C140 Adrenocorticotrophin 53 3 894,48
C452 Determination of cortisol in saliva 25 1 837,02
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 408,85
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 104 7 642,00
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 9 332,06
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 9 332,06
G123 Mucoviscidosis CFTR 300 22 044,24
G149 FISH analysis of sperm nucleus (X, Y + 1 somatic chromosome) 200 14 696,16
G150 Analysis of DNA fragmentation in sperm by Halosperm with spermogram 200 14 696,16
G151 Electronic misroscopic analysis of sperm (EMAS) 250 18 370,20
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 380,12
C132 Parathormone 47 3 453,60
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 233,16
C147 Bone resorption - deoxypiridinolin 67 4 923,21
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 5 878,46
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 380,12
B527 Somatomedin-C 46 3 380,12
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 2 939,23
B533 Proinsulin 60 4 408,85
B534 С-peptide 47 3 453,60
B539 Antibody-GAD 53 3 894,48
C108 Leptin 53 3 894,48
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 511,06
C158 Melatonin 48 3 527,08
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 3 894,48
BIOGENIC AMINES
C700 Serotonin 60 4 408,85
C800 Histamine 60 4 408,85
C900 Tryptase 75 5 511,06
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 408,85
C157 Catecholamines and serotonin 36 2 645,31
S100 Determination of Metanefrine (total) in daily urine 93 6 833,71
S101 Determination of Metanefrine (free) in daily urine 93 6 833,71
S102 Determination of Normetanefrine (total) in daily urine 93 6 833,71
S103 Determination of Normetanefrine (free) in daily urine 93 6 833,71
S104 Determination of Vanillylmendalic acid in daily urine 93 6 833,71
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 469,62
C311 Specific IgE for Allergen Mix / qual 33 2 424,87
C312 Single recombinant allergic components, inhalation (One name) 20 1 469,62
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 808,29
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 469,62
C315 General Inhalation Allergy Panel 160 11 756,93
C340 General Food Panel 160 11 756,93
C350 Allergy Panel/ primary screening 120 8 817,70
C351 Allergy pediatric panel, IgE (20 allergens) 156 11 463,00
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 2 057,46
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 616,58
С362 Antibacterial drugs (antibiotics) (specific IgE), one name. 9 661,33
С363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 9 661,33
С364 Local anesthetics (specific IgE). One name. 9 661,33
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 17 1 249,17
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 17 1 249,17
C367 Local anesthetics (specific IgG). One name. 17 1 249,17
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 1 983,98
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 616,58
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 31 229,34
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 881,77
C312 Single recombinant allergic components, inhalation (One name) 16 1 175,69
C313 Single recombinant allergic components, nutritional (group 1) (One name) 8 587,85
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 16 1 175,69
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 23 513,86
С360 Complex diagnostics of food intolerance (panel of 96 tests): specific IgG4 to 115 products (85 individual and 30 mixed doubles), Ascaris, Candida), Dr.Fooke 216 15 871,85
С361 Complex diagnostics of food intolerance (panel of 192 tests): specific IgG4 to 203 products (181 individual and 22 mixed doubles), Ascaris, Candida), Dr.Fooke 347 25 497,84
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 571,83
P019 DNA Salmonella species in stool 25 1 837,02
P021 Colibacillosis 40 2 939,23
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 865,75
P009 Mycoplasma pneumoniae DNA 22 1 616,58
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 4 923,21
P030 HSV I & II 20 1 469,62
P031 Human Papilloma virus 31, 33 20 1 469,62
P032 Human Papilloma virus 6,11 20 1 469,62
P033 Herpes Simplex virus II 20 1 469,62
P035 H. Papilloma virus 16, 18 20 1 469,62
P042 Varicella-Zoster virus 20 1 469,62
P070 Cytomegalovirus 20 1 469,62
P080 Epstein-Barr virus 20 1 469,62
P105 Human Papilloma virus sp. 20 1 469,62
P004 Rubella Virus in blood (qual) 40 2 939,23
P120 Herpes Simplex virus VI (qual) 18 1 322,65
P125 Enterovirus (RNA) 33 2 424,87
P126 DNA Pneumocystis carinni 17 1 249,17
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 674,04
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 5 143,66
P129 RNA Zika virus (blood) 80 5 878,46
P130 RNA Zika virus (ejaculate) 33 2 424,87
P131 RNA Zika virus (Amniotic fluid) 33 2 424,87
P132 РНК HIV (quantitative) 105 7 715,48
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 5 143,66
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 204,42
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 102,21
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 469,62
P036 M.Tuberculosis-M.bovis 22 1 616,58
P038 Streptococcus group A (pyogenes) 22 1 616,58
P065 Listeria monocytogenes 22 1 616,58
P075 Pseudomonas aeruginosa 22 1 616,58
P085 Bordetella pertussis (PCR) 22 1 616,58
P090 Bordetella sp. 22 1 616,58
P095 Helicobacter pylori 38 2 792,27
P097 Haemophilus influenzae 20 1 469,62
P098 Streptococcus pneumoniae 20 1 469,62
P099 DNA Treponema pallidum 20 1 469,62
P103 Legionella pneumophila 10 734,81
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 469,62
P005 Mycoplasma hominis 20 1 469,62
P006 Mycoplasma genitalium 20 1 469,62
P015 Ureaplasma species 20 1 469,62
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 469,62
P020 Neisseria gonorrhoeae 20 1 469,62
P025 Gardnerella vaginalis 20 1 469,62
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 469,62
P012 Toxoplasma gondii 22 1 616,58
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 616,58
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 3 894,48
P045 Hepatitis B qualitive (HBV-DNA) 33 2 424,87
P050 Hepatitis C quant. (HCV-RNA) 253 18 590,64
P055 Hepatitis C qualitive (HCV-RNA) 38 2 792,27
P060 HCV-RNA (genotype determination) 40 2 939,23
P061 Hepatite G qual. (HGV-RNA) 40 2 939,23
P062 Hepatite D qual. (HDV-RNA) 40 2 939,23
P008 Hepatitis A Virus RNA (HAV-RNA) 40 2 939,23
P007 Determination of DNA of hepatitis TT virus (qual.) (TTV-DNA) 33 2 424,87
P063 Genotype of hepatitis B 35 2 571,83
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 511,06
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 13 667,43
P132 РНК HIV (quantitative) 76 5 584,54
GENETIC ANALYSIS
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 11 022,12
G122 SNP identification in human IL28B gene 60 4 408,85
G124 Genetic panel "Hypertension" 220 16 165,78
G125 Genetic panel "Ischemic heart disease" 230 16 900,58
G126 Genetic panel "Lipid metabolism, base panel" 220 16 165,78
G127 Genetic panel "Plasma factors of coagulation system" 220 16 165,78
G128 Genetic panel "Aggregation factors of coagulation system" 220 16 165,78
G129 Genetic panel "Folate cycle" 220 16 165,78
G130 Genetic panel "Osteoporosis" 250 18 370,20
G131 Genetic panel "Obesity" 220 16 165,78
G132 Genetic panel "Crohn's disease" 230 16 900,58
G133 Genetic panel "Warfarin" 250 18 370,20
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 16 900,58
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 15 430,97
G136 FISH panel Myelodysplastic syndrome (6 probes) 220 16 165,78
G137 CYP2D6 analysis polymorphisms 140 10 287,31
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 31 596,74
G139 Familial adenomatous polyposis , polypoid colon cancer 430 31 596,74
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 42 177,98
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 60 254,26
G156 BRCA1 и BRCA2 polymorphism 225 16 533,18
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1125 82 665,90
G159 Sequence SCN1 A (Dravet syndrome) 825 60 621,66
G160 Fragile X mental retardation syndrome (methylation) 188 13 814,39
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 19 325,45
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 124 917,36
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 9 919,91
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 2 939,23
G165 Paternity test 480 35 270,78
G167 Non Invasive Fetal Rhesus factor Determination 188 13 814,39
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 11 022,12
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 760 55 845,41
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 760 55 845,41
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1000 73 480,80
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 51 436,56
G197 Calreticulin (CALR) 77 5 658,02
G198 Ehlers-Danlo syndrome type IV. Search for frequent mutations in the PLOD1 gene 130 9 552,50
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 538 39 532,67
G208 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (optimal) 132 9 699,47
G209 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (expanded) 732 53 787,95
G210 Predisposition to osteoporosis 95 6 980,68
G211 Sports injury (professional sports) 156 11 463,00
G212 Choosing sport - strength or speed 120 8 817,70
G213 Stamina (career guidance) 84 6 172,39
G214 Stress resistance (career guidance) 108 7 935,93
G215 Acne 348 25 571,32
G216 Genetic predisposition to breast cancer and ovarian cancer 120 8 817,70
G217 Genetic predisposition to cervical cancer (economy) 156 11 463,00
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 16 900,58
G222 Genetic predisposition to thrombophilia (early gestation, preparing for pregnancy and childbirth) 230 16 900,58
G224 Genetic predisposition to late gestosis and preeclampsia 175 12 859,14
G226 Genetic predisposition to hirsutism and hyperandrogenism 36 2 645,31
G227 Genetic predisposition to metabolic syndrome 252 18 517,16
G228 The sensitivity of the androgen receptor 108 7 935,93
G229 Skin cancer, melanoma (genetical) 228 16 753,62
G230 Cancer of the oral cavity and nasopharynx 60 4 408,85
G231 Esophageal cancer 156 11 463,00
G232 Stomach cancer 396 29 098,40
G233 Pancreas cancer 84 6 172,39
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 560 41 149,25
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 14 696,16
G236 Sensitivity of steroid receptors (estrogen, progesterone) 150 11 022,12
G237 Metabolism of steroid hormones genetic distinction 276 20 280,70
G238 Genetic predisposition to disruption of spermatogenesis 36 2 645,31
G239 Genetic predisposition to adrenal cortex function decreasing 175 12 859,14
G240 Genetic predisposition to a decrease in testosterone synthesis 95 6 980,68
G241 Genetic predisposition to hyperandrogenism 36 2 645,31
G242 Medullar thyroid cancer 132 9 699,47
G243 Follicular thyroid cancer 60 4 408,85
G244 Upper respiratory tract and esophagus cancer 252 18 517,16
G245 Allergy 84 6 172,39
G246 Bronchial asthma 108 7 935,93
G247 Bronchial asthma. Steroids resistance 60 4 408,85
G248 Body mass index 84 6 172,39
G249 Rheumatoid arthritis 45 3 306,64
G250 Psoriatic arthritis 60 4 408,85
G251 Atherosclerosis, coronary artery disease, dyslipidemia 175 12 859,14
G252 Hypertension 200 14 696,16
G253 Atherosclerotic index 150 11 022,12
G254 Sensorineural hearing loss 36 2 645,31
G255 Muscle atrophy 60 4 408,85
G256 Long QT syndrome 84 6 172,39
G257 Myopia 156 11 463,00
G258 Candidal vaginitis 60 4 408,85
G259 Bacterial vaginosis 108 7 935,93
G260 Hyperactivity 156 11 463,00
G261 Psychotrauma 204 14 990,08
G262 Localized scleroderma 84 6 172,39
G263 Utilization of xenobiotics rate 60 4 408,85
G264 Lactose intolerance 67 4 923,21
G265 Gilbert's syndrome - a confirmatory test 40 2 939,23
G266 Type 1 diabetes 132 9 699,47
G267 Type 2 diabetes 114 8 376,81
G268 Psoriasis 60 4 408,85
G269 Atopic dermatitis 132 9 699,47
G270 Determination of sensitivity to irinotecan (Campto) (treatment of сolorectal cancer) 36 2 645,31
G271 Determination of sensitivity to Erbitux and Vectibix (treatment of сolorectal cancer) 108 7 935,93
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 36 2 645,31
G273 Determination of sensitivity to Iressa, Tarceva (lung cancer treatment) 36 2 645,31
G274 Determination of sensitivity to Herceptin (cardiotoxicity) 36 2 645,31
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 12 197,81
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 12 197,81
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 191 14 034,83
G289 Activity GATA2 gene for prostate cancer (blood test) 166 12 197,81
G290 Activity IGF1 gene for prostate cancer (blood test) 166 12 197,81
G291 Activity IGF2 gene for prostate cancer (blood test) 166 12 197,81
G292 Activity IL4 gene for prostate cancer (blood test) 166 12 197,81
G293 Activity IL10 gene for prostate cancer (blood test) 166 12 197,81
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 264 19 398,93
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 111 8 156,37
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 548 40 267,48
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 913 67 087,97
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 406 29 833,20
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1420 104 342,74
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2435 178 925,75
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4058 298 185,09
G308 PGD ​​monogenic diseases 1 category of complexity 1217 89 426,13
G309 PGD ​​monogenic diseases 2 category of complexity 2029 149 092,54
G310 PGD ​​monogenic diseases 2 category of complexity 3043 223 602,07
G311 Genetic aptitude to myocardial infarction 175 12 859,14
G312 Genetic aptitude to enlargement of apoplectic attack 108 7 935,93
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 435 31 964,15
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 535 39 312,23
G315 Full sequencing of exome 2046 150 341,72
G316 Panel "Diseases of conjunctive tissue" 640 47 027,71
G317 Panel "Patrimony of cardiopathy" 614 45 117,21
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 625 45 925,50
G319 Search for mutations in the gene CAV 3 129 9 479,02
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 44 455,88
G321 Panel "Hypertension" 80 5 878,46
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 10 287,31
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 345 25 350,88
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 172 12 638,70
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 550 40 414,44
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 227 16 680,14
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 155 11 389,52
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 155 11 389,52
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 742 54 522,75
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 536 39 385,71
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 227 16 680,14
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 16 900,58
G333 Myriad MyRisk 3180 233 668,94
G334 Myriad BRCA1 Analysis 1780 130 795,82
G335 Myriad BRCA2 Analysis 1850 135 939,48
G336 Myriad COLARIS PLUS 2490 182 967,19
G337 Myriad MLH1 Analysis 1495 109 853,80
G338 Myriad MSH2 Analysis 1285 94 422,83
G339 Myriad MSH6 Analysis 1600 117 569,28
G340 Myriad PMS2 Analysis 1495 109 853,80
G341 Myriad MYH Sequence Analysis 1425 104 710,14
G342 Myriad Comprehensive MELARIS 960 70 541,57
G343 Myriad Comprehensive PANEXIA 2490 182 967,19
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 511,06
G345 Molecular genetic testing for SPAST-gene mutation associated with Hereditary spastic paraplegia (HSP) 505 37 107,80
G346 Molecular genetic testing for ATL1-gene mutation associated with Hereditary spastic paraplegia (HSP) 464 34 095,09
G347 Molecular genetic testing for BSCL2-gene mutation associated with Hereditary spastic paraplegia (HSP) 217 15 945,33
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 11 022,12
G349 Molecular genetic testing for GJC2-gene mutation associated with Hereditary spastic paraplegia (HSP) 138 10 140,35
G350 Molecular genetic testing for CYP2U1-gene mutation associated with Hereditary spastic paraplegia (HSP) 159 11 683,45
G351 Molecular genetic testing for L1CAM-gene mutation associated with Hereditary spastic paraplegia (HSP) 556 40 855,32
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 58 4 261,89
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 167 12 271,29
G355 Myriad BRAC Analysis 2135 156 881,51
G356 Myriad Single-Site BRACAnalysis 500 36 740,40
G357 Myriad MultiSite 3 BRACAnalysis 605 44 455,88
G358 Myriad Reflex BRACAnalysis 1925 141 450,54
G359 Myriad BRACAnalysis Rearrangement Test (BART) 750 55 110,60
G360 Myriad Single-Site COLARIS 500 36 740,40
G361 Myriad COLARIS AP PLUS 2135 156 881,51
G362 Myriad Single-Site COLARIS AP 500 36 740,40
G363 Myriad MYH Mutation Panel 430 31 596,74
G364 Myriad Reflex MYH Sequence Analysis 1195 87 809,56
G365 Myriad Single-Site MELARIS 500 36 740,40
G366 Myriad Single-Site PANEXIA 500 36 740,40
G367 Myriad PALB2 Analysis 1540 113 160,43
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 76 420,03
G376 Molecular karyotyping abortion material OPTIMA 285 20 942,03
G377 Chromosomal micrometrical analysis of abortive material Standard 530 38 944,82
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 580 42 618,86
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 420 30 861,94
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 400 29 392,32
G388 The allocation and storage of DNA 20 1 469,62
G389 Panel "Disorders of hemostasis" 30 tokens 210 15 430,97
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 10 801,68
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 9 772,95
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 17 929,32
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 26 085,68
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 26 085,68
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 20 354,18
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 26 893,97
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 22 779,05
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 16 312,74
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 14 696,16
TISSUE TYPING
G020 HLA TYPING B27 200 14 696,16
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 5 878,46
M003 Bacterioscopic stained smear 30 2 204,42
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 453,60
M010 Mycology & Fungigram 74 5 437,58
M100 Disbacteriosis 107 7 862,45
M130 Corynebacterium diphtheriae (BL) 29 2 130,94
M135 Enteropathogenic bacteria (BD) 29 2 130,94
M170 Staphylococcus aureus 52 3 821,00
M350 Yersinia enterocolitica (stool culture) 52 3 821,00
M560 Listeria (with resistance) 38 2 792,27
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 15 1 102,21
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 469,62
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 102,21
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 102,21
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 52 3 821,00
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 52 3 821,00
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 11 808,29
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 11 022,12
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 348,08
M151 Microbiology of blood by fungi (double reseeding) 130 9 552,50
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 5 878,46
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 9 552,50
M156 Mycology of sputum by fungi, microscopy and culture 80 5 878,46
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 9 552,50
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 8 082,89
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 817,70
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 5 878,46
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 348,08
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 817,70
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 5 143,66
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 5 878,46
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 613,27
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 8 450,29
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 5 878,46
COMPLEX LABORATORY TESTS
K011 Fibro Test/ Acti Test 300 22 044,24
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 27 922,70
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 539,79
G100 TIMP-2 - study of lung cancer invasiveness 89 6 539,79
G008 TGF B - study of prostate cancer invasiveness 89 6 539,79
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 674,04
G010 BRCA1 4153delA 50 3 674,04
G011 BRCA1 185delAG 50 3 674,04
G012 BRCA1 C61>G 50 3 674,04
G014 BRCA1 2080delAA 50 3 674,04
G015 BRCA2 6174delT 50 3 674,04
G016 BRCA2 9318 delAAAA 50 3 674,04
G021 CHEK2 ivs2+1G>A 50 3 674,04
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 6 245,87
G053 BCR-ABL p190 t(9;22) 85 6 245,87
G054 BCR-ABL p230 t(9;22) 85 6 245,87
MUTATIONS, CHIMERISM
G097 Mutation in D816V gene c-KIT, typical of mastocytosis 94 6 907,20
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 11 022,12
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 539,79
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 408,85
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 4 114,92
G107 Deletion in 12 exon gene Jak-2 kinase 80 5 878,46
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 7 715,48
G152 Germinal mutation 60 4 408,85
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 7 715,48
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 680 49 966,94
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 83 6 098,91
G374 Prenatal DNA diagnosis (Wilson's Disease) 167 12 271,29
G381 PMP22(1.5-MB Del) 24 1 763,54
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 24 1 763,54
G383 PMP22 (1-BP INS, 325G; rs80338763) 24 1 763,54
G384 PMP22 (Ala67Thr: rs104894623) 24 1 763,54
G385 PMP22 (EX2-3DEL; nsv1197510) 24 1 763,54
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 6 245,87
G387 Genotyping on the RH factor, including heterozygous carrier 126 9 258,58
G390 Panel "Phacomatosis and hereditary cancer" 630 46 292,90
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 9 332,06
G408 Analysis of carriers of spinal ametropia 144 10 581,24
G409 Screening for hereditary diseases (2500 genes) 632 46 439,87
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 408,85
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 15 357,49
G412 Search 9 most frequent mutations in the CYP210HB gene 144 10 581,24
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 12 565,22
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 5 731,50
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 81 416,73
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 89 499,61
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 112 278,66
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 120 435,03
G420 Confirmation of previously found mutation sequencing by Sanger 107 7 862,45
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 15 651,41
H250 Histology of tumor surgical samples 389 28 584,03
H299 Intraoperative (urgent) histology and cytology 200 14 696,16
H270 Histology of breast wide local excision (lumpectomy) specimen 389 28 584,03
H271 Histology of mastectomy speciment 367 26 967,45
H272 Histology of sentinel lymph node with IHC if necessary 227 16 680,14
H273 Histology of lymph node dissection speciment 213 15 651,41
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 9 332,06
M202 Hystology with supplementary staining for helicobacter pylori 227 16 680,14
M203 Multiple histology 3 samples and more 344 25 277,40
H204 Histology of the prostate punctates 358 26 306,13
H205 Histology of scrapings of the uterus 213 15 651,41
H206 Histology of the mammary gland punctates 213 15 651,41
H207 Histology of liver bioptates 213 15 651,41
H208 Histology of CT-guideline needle biopsy 397 29 171,88
H209 Histology of skin (PUNCH-biopsy) 213 15 651,41
H210 Histology of skin tumors 198 14 549,20
H211 Histology of bone marrow patho bioptate 213 15 651,41
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 11 463,00
H231 Consultation with the making of histology specimens with paraffin blocks 224 16 459,70
H232 Consultation with the making of specimens and immunohistochemistry 358 26 306,13
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 28 584,03
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 760,23
CYTOLOGY
M300 Citology / 1 lame 75 5 511,06
M301 Cytologic cervical smear (Pap Smear) 94 6 907,20
M302 Integrated cytology PAP-test and HPV typing 115 8 450,29
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 731,50
Z303 Cytology of the mammary gland 75 5 511,06
Z304 Cytology of the thyroid gland punctate 117 8 597,25
Z305 Cytology of liquid 78 5 731,50
Z306 Cytology of endoscopic material 56 4 114,92
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 731,50
Z308 Cytology of surgical samples 78 5 731,50
Z309 Cytology of the lymph nodes punctate 94 6 907,20
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 731,50
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 20 1 469,62
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 20 427,66
I002 Immunohistochemical differential diagnosis of tumors 389 28 584,03
I003 Immunohistochemistry of one marker panel differential diagnosis 89 6 539,79
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 33 580,73
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 198 14 549,20
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 11 463,00
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 29 392,32
I501 Determination of methylation of promoter and MGMT gene body in biopsic (surgical) material 255 18 737,60
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 21 088,99
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 21 088,99
G202 EGFR gene amplification (sensitivity to cetuximab) 259 19 031,53
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 13 079,58
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 17 341,47
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 8 229,85
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 24 101,70
G207 Determination of the methylation status of the promoter body and MGMT gene 177 13 006,10
G275 BCAM gene activity in cancer of the thyroid gland (biopsy study) 159 11 683,45
G276 IL4 gene activity in cancer of the thyroid gland (biopsy study) 159 11 683,45
G277 IL10 gene activity in cancer of the thyroid gland (biopsy study) 159 11 683,45
G278 TG gene activity in cancer of the thyroid gland (biopsy study) 159 11 683,45
G279 Active genes BCAM, IL4, IL10, TG thyroid cancer (study biopsy) 229 16 827,10
G283 Activity GATA2 gene for prostate cancer (study biopsy) 159 11 683,45
G284 Activity IGF1 gene for prostate cancer (study biopsy) 159 11 683,45
G285 Activity IGF2 gene for prostate cancer (study biopsy) 159 11 683,45
G286 Activity IL4 gene for prostate cancer (study biopsy) 159 11 683,45
G287 Activity IL10 gene for prostate cancer (study biopsy) 159 11 683,45
G288 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (study biopsy) 252 18 517,16
G368 Tissue test in ovarian cancer treatment 3213 236 093,81
G369 Agression degree in prostate cancer 3570 262 326,46
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 3543 260 342,47
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 178 999,23
G404 Express research of additional biomarkers 226 16 606,66
G405 Biological profiling of tumor (Caris Target Now) only NGS 3500 257 182,80
G406 Biological profiling of tumor (Caris Target Now) full profile 5700 418 840,56
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 249 18 296,72
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 18 296,72
I504 Translocation in synovial sarcoma SYT/SSX 249 18 296,72
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 249 18 296,72